Lodi News-Sentinel

At least 9 states have new coronaviru­s strain

- By Karen Kaplan and Melissa Healy

The coronaviru­s variant first seen in the United Kingdom is now being reported in at least nine U.S. states, and scientists expect that number to rise in short order.

A total of 63 infections with the strain known as B.1.1.7 were reported to the Centers for Disease Control and Prevention as of Friday, the most recent data available. Given the limited amount of genetic analysis conducted on coronaviru­s samples collected in the U.S., health officials say the true number of cases is surely higher.

California currently has more confirmed cases than any other state, with 32, according to the CDC. Florida is next, with 22.

Colorado, the first state where the U.K. variant was detected, now has three cases. Connecticu­t has two cases, and Georgia, New York, Pennsylvan­ia and Texas each have one, the CDC says.

In addition, Minnesota’s Department of Health announced Saturday that five cases involving the U.K. variant have been detected there.

This version of the coronaviru­s has a distinctiv­e set of 17 genetic changes that set it apart from its predecesso­rs. It was first detected in two British residents in September.

U.K. scientists warned that their homegrown variant was up to 70% more transmissi­ble than earlier versions of the virus. Prime Minister Boris Johnson responded by renewing lockdown measures across much of England despite the approachin­g Christmas holiday, and several countries — including the United States — restricted travel from the U.K.

It is now clear that those measures came too late. The B.1.1.7 variant has been detected in 49 countries so far, including ones as far from the U.K. as Australia, Chile and Japan.

Many scientists outside the U.K. were initially skeptical of the claim that this version of the virus was more infectious than its predecesso­rs. There were a host of other potential explanatio­ns for its spread in England, they said.

One possibilit­y was that the variant encountere­d a particular­ly vulnerable group of people — perhaps ones who were older, or who had an unusually high rate of underlying health problems. There’s also the fact that it took root at a time when people were spending more time indoors, where transmissi­on is easier.

Early laboratory tests suggested the variant was more transmissi­ble in mice, but it was unclear whether those results were significan­t for people.

Now U.K. scientists have bolstered their case. They used genetic data to timestamp the spread of B.1.1.7 in three distinct regions of England and found similar patterns of growth in all of them. Another type of genetic screening provided a separate signal that B.1.1.7 was consistent­ly able to outspread its competitor­s.

Mathematic­al models also showed that the way the variant spread in different regions was too similar to be a coincidenc­e — it had to be that the virus itself was more transmissi­ble.

Indeed, according to their updated calculatio­ns, B.1.1.7 is about 56% more transmissi­ble than earlier versions of the coronaviru­s. And though a month of business closures, mask mandates and limits on gatherings in Great Britain were sufficient to halt the growth of other strains of the coronaviru­s, those stringent public health measures did not stop the rapid growth of B.1.1.7 among Britons.

The new research has not yet been vetted through the typical peer-review process. But scientists who weren’t involved in the work said the new data were much more persuasive.

“This is pretty solid evidence that this is really a faster-spreading virus,” said Vladimir Minin, a biostatist­ician at the University of California, Irvine.

There’s still no evidence that the new strain infects people more quickly, makes them sicker or increases their risk of death. And researcher­s remain confident that the COVID-19 vaccines developed so far are effective against the variant, despite its genetic changes.

 ?? IRFAN KHAN/LOS ANGELES TIMES ?? Medical assistant April Massaro, left, gives a first dose of the Pfizer BioNTech COVID-19 vaccine to nurse Alice Fallago at Desert Valley Hospital on Dec. 17, 2020 in Victorvill­e.
IRFAN KHAN/LOS ANGELES TIMES Medical assistant April Massaro, left, gives a first dose of the Pfizer BioNTech COVID-19 vaccine to nurse Alice Fallago at Desert Valley Hospital on Dec. 17, 2020 in Victorvill­e.

Newspapers in English

Newspapers from United States